| Literature DB >> 35335127 |
Chih-Hua Chao1,2, Yi-Ju Chen3, Chiung-Yao Huang3, Fang-Rong Chang4, Chang-Feng Dai5, Jyh-Horng Sheu3,4,6.
Abstract
In an attempt to explore the bioactive metabolites of the soft coral Sarcophyton cinereum, three new cembranolides, cinerenolides A-C (1-3), and 16 known compounds were isolated and identified from the EtOAc extract. The structures of the new cembranolides were elucidated on the basis of spectroscopic analysis, and the NOE analysis of cinerenolide A (1) was performed with the assistance of the calculated lowest-energy molecular model. The relative configuration of cinerenolide C (3) was determined by the quantum chemical NMR calculation, followed by applying DP4+ analysis. In addition, the cytotoxic assays disclosed that some compounds exhibited moderate to potent activities in the proliferation of P388, DLD-1, HuCCT-1, and CCD966SK cell lines.Entities:
Keywords: Sarcophyton cinereum; cinerenolides A–D; cytotoxity; α,β-unsaturated ε-lactone
Mesh:
Substances:
Year: 2022 PMID: 35335127 PMCID: PMC8956058 DOI: 10.3390/molecules27061760
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
1H NMR spectroscopic data of compounds 1–3.
| 1 a | 2 b | 2 c | 3 b | |
|---|---|---|---|---|
| No. | ||||
| 2 | 6.13 d (11.6) | 5.40 d (16.4) | 5.37 d (16.4) | 5.44 d (16.0) |
| 3 | 5.82 d (11.6) | 5.53 d (16.4) | 5.52 d (16.4) | 5.43 d (16.0) |
| 5 | 4.19 (11.0, 8.0, 4.0) | 1.84 m | 1.98 m | 1.74 m |
| 1.73 m | 1.82 m | |||
| 6 | 2.30 m | 1.66 m | 1.66 m | 1.82 m |
| 1.89 m | 1.46 m | 1.66 m | 1.37 m | |
| 7 | 4.11 dd (9.2, 8.4) | 3.92 d (10.8) | 3.75 d (10.0) | 3.79 d |
| 9 | 2.21 m | 2.24 m | 2.23 m | 2.20 m |
| 2.06 m | 1.95 m | 2.00 m | 1.89 m | |
| 10 | 2.58 m | 2.69 m | 2.53 m | 2.67 m |
| 2.40 m | 2.52 m | 2.50 m | 2.45 m | |
| 11 | 6.08 t (3.6) | 6.55 t (3.9) | 6.51 t (5.0) | 6.49 s |
| 13 | 3.17 t (12.2) | 2.90 td (12.0, 4.0) | 3.09 m | 2.72 m |
| 1.84 m | 2.22 m | 2.50 m | 2.38 m | |
| 14 | 2.57 td (12.2, 8.0) | 1.92 m | 1.90 m | 2.27 m |
| 2.13 m | 1.79 m | 1.81 m | 1.67 m | |
| 15 | 2.33 m | 1.70 m | 1.80 m | 1.60 m |
| 16 | 1.10 d (6.8) | 0.89 d (6.8) | 0.85 d (6.8) | 0.87 d (6.4) |
| 17 | 1.06 d (6.8) | 0.81 d (6.8) | 0.80 d (6.8) | 0.83 d (6.4) |
| 18 | 1.92 s | 1.26 s | 1.30 s | 1.25 s |
| 19 | 1.41 s | 1.29 s | 1.31 s | 1.26 s |
| 5-OH | 1.38 d (8.0) | |||
| 7-OH | 1.24 d (8.4) |
a Spectra recorded at 400 MHz in CDCl3; b spectra recorded at 400 MHz in CD3OD; c spectra recorded at 500 MHz in CDCl3.
13C NMR spectroscopic data of compounds 1–3.
| 1 a | 2 b | 2 c | 3 b | |
|---|---|---|---|---|
| No. | ||||
| 1 | 149.9 (C) | 77.0 (C) | 74.5 (C) | 77.1 (C) |
| 2 | 118.5 (CH) | 135.1(CH) | 134.8 (CH) | 132.4 (CH) |
| 3 | 123.0 (CH) | 135.1(CH) | 133.4 (CH) | 135.1(CH) |
| 4 | 133.3 (C) | 74.9 (C) | 73.8 (C) | 74.0 (C) |
| 5 | 73.0 (CH) | 37.5 (CH2) | 34.0 (CH2) | 36.9 (CH2) |
| 6 | 36.0 (CH2) | 25.6 (CH2) | 25.6 (CH2) | 25.2 (CH2) |
| 7 | 67.5 (CH) | 71.7 (CH) | 72.2 (CH) | 70.2 (CH) |
| 8 | 83.0 (C) | 86.1 (C) | 83.9 (C) | 85.7 (C) |
| 9 | 34.1 (CH2) | 35.3 (CH2) | 36.6 (CH2) | 35.8 (CH2) |
| 10 | 27.3 (CH2) | 28.4 (CH2) | 27.9 (CH2) | 28.3 (CH2) |
| 11 | 140.5 (CH) | 144.8 (CH) | 144.0 (CH) | 145.2 (CH) |
| 12 | 133.2 (C) | 134.8 (C) | 134.2 (C) | 132.6 (C) |
| 13 | 37.4 (CH2) | 32.9 (CH2) | 32.0 (CH2) | 35.6 (CH2) |
| 14 | 27.2 (CH2) | 39.0 (CH2) | 38.0 (CH2) | 36.8 (CH2) |
| 15 | 35.7 (CH) | 38.4 (CH) | 40.1 (CH) | 43.4 (CH) |
| 16 | 22.1 (CH3) | 16.8 (CH3) | 16.7 (CH3) | 17.1 (CH3) |
| 17 | 22.8 (CH3) | 17.4 (CH3) | 16.9 (CH3) | 18.0 (CH3) |
| 18 | 17.2 (CH3) | 31.9 (CH3) | 32.0 (CH3) | 32.5 (CH3) |
| 19 | 22.0 (CH3) | 22.5 (CH3) | 21.7 (CH3) | 22.7 (CH3) |
| 20 | 166.5 (C) | 170.4 (C) | 168.7 (C) | 169.3 (C) |
a Spectra recorded at 100 MHz in CDCl3; b spectra recorded at 100 MHz in CD3OD; c spectra recorded at 125 MHz in CDCl3.
Figure 1Selected 1H–1H COSY (▬) and HMBC (→) correlations of 1–3.
Figure 2Selected NOE correlations of 1–3.
Figure 3Low-energy conformers, populations, and dihedral angles (Φ1 (H7-C7-C6-H6) and Φ2 (H7-C7-C6-H6)) of 7S*, 8R*-1 at CAM-B3LYP/6-31+G(d,p) IEFPCM (CHCl3) level of theory.
Figure 4Low-energy conformers, populations, key proton-proton distances, and dihedral angles (Φ1 (H7-C7-C6-H6) and Φ2 (H7-C7-C6-H6)) of 7R*, 8R*-1 (epi-1) at CAM-B3LYP/6-31+G(d,p) IEFPCM (CHCl3) level of theory.
Scheme 1Structures of compounds 1–19.
DP4+ probabilities for possible isomers of compound 3.
|
| ||||
| 1α4β- | 1β4α- | 1α4α- | 1β4β- | |
| H | 100.00% | 0% | 0% | 0% |
| C | 100.00% | 0% | 0% | 0% |
| All data | 100.00% | 0% | 0% | 0% |
Anti-proliferation activities (IC50, μM) of 2–19.
| Compound | P388 a | DLD-1 b | HuCCT-1 c | CCD966SK d |
|---|---|---|---|---|
|
| >30 | >30 | >30 | >30 |
|
| >30 | >30 | >30 | >30 |
|
| >30 | >30 | >30 | >30 |
|
| 15.2 ± 3.2 | >30 | >30 | >30 |
|
| 11.8 ± 4.6 | >30 | >30 | >30 |
|
| >30 | >30 | >30 | >30 |
|
| >30 | >30 | >30 | >30 |
|
| >30 | >30 | >30 | >30 |
|
| >30 | >30 | >30 | >30 |
|
| >30 | >30 | >30 | >30 |
|
| >30 | >30 | >30 | >30 |
|
| >30 | >30 | >30 | >30 |
|
| >30 | >30 | >30 | >30 |
|
| >30 | >30 | >30 | 27.6 ± 7.8 |
|
| 16.7 ± 5.8 | >30 | 19.1 ± 6.4 | 21.3 ± 5.8 |
|
| 22.8 ± 9.7 | >30 | >30 | 26.1 ± 10.3 |
|
| 10.6 ± 1.9 | 9.9 ± 1.0 | 2.0 ± 0.1 | 18.8 ± 6.9 |
|
| >30 | >30 | >30 | 18.8 ± 6.8 |
| Doxorubicin | 0.69 ± 0.01 | 4.1 ± 0.7 | 1.9 ± 0.1 | 2.9 ± 0.4 |
a mouse lymphoma. b human colorectal adenocarcinoma. c human intrahepatic cholangiocarcinoma. d human skin fibroblast.